Dose daily

Genentech Announces Pivotal Phase III Data for Divarasib Demonstrating Significant Survival Benefits in KRAS G12C-Mutated Lung Cancer

Genentech, a member of the Roche Group, today announced positive results from the pivotal Phase III Krascendo 1 clinical trial evaluating divarasib, an investigational targeted inhibitor, in patients with previously treated KRAS G12C-mutated non-small...

Corxel Pharmaceuticals to Go Public via $377 Million Business Combination to Accelerate Next-Generation Oral Obesity Pipeline

Corxel Pharmaceuticals announced today that it has entered into a definitive business combination agreement with AmanatAcquisition Corp. to take its...

Bayer Secures Regulatory Approval in China for Asundexian to Prevent Recurrent Ischemic Stroke

Bayer announced  that it has gained regulatory approval in China for asundexian, its oral factor XIa (FXIa) inhibitor developed to prevent...

Amgen and AstraZeneca Present Groundbreaking Oncology Data at ESMO, Demonstrating a 58% Reduction in Risk of Death for Small Cell Lung Cancer

Amgen and AstraZeneca presented practice-changing Phase 3 clinical data at the European Society for Medical Oncology (ESMO) 2026 Congress,...

​Next-Generation MAKO 4 Robotic-Assisted Surgery System Officially Launched to Advance Precision in Joint Replacement

In a major development for orthopedic surgical technology, medical device innovators and surgical teams have celebrated the official rollout of...

Dr. Reddy’s Launches Affordable Oral Diabetes Drug in India

Dr. Reddy’s Laboratories has announced the launch of Obeda®, its oral semaglutide tablet for the treatment of Type 2 diabetes in India. The once-daily tablet...

North Bengal Set to Transform into a Leading Pharma Destination

West Bengal is intensifying its focus on pharmaceutical manufacturing as part of a broader industrial development strategy aimed at attracting investment and boosting economic...

Global Health Alert: WHO Raises Alarm Over Ebola Surge in DR Congo and Uganda

The World Health Organization (WHO) has declared the ongoing Ebola outbreak in the Democratic Republic of Congo (DRC) and neighboring Uganda a Public Health...

New Hope for Neuro care: Lupin Opens “Atharv” An Advanced Ability Center in Delhi

Lupin has inaugurated Atharv Ability, an advanced multidisciplinary neuro-rehabilitation center in Delhi, marking a significant step toward strengthening specialized neurological care in India. The facility...

WHO Flags Rising Nicotine Pouch Trend Targeting Youths as Public Health Threat

The World Health Organization has raised serious concerns over the growing popularity of nicotine pouches, warning that aggressive youth-focused marketing could trigger a new wave of...

A New Era in Child Healthcare: Eli Lilly and UNICEF Forge Landmark Global Alliance

Eli Lilly and Company and UNICEF have announced a landmark global partnership aimed at improving healthcare access and disease prevention for millions of children...